Natalia Blanco
Company: Morphic Therapeutics
Job title: Associate Director - Immuno-Oncology
Seminars:
Employing Small Molecule Design as a Safeguard Against Toxicity of TGF-β Targeted Therapies 11:30 am
Targeting TGF-β activation to reduce unwanted side effects Making treatments directed to TGF-β safe and efficacious by stimulating T cell responses and reducing fibrosis Exploring response of αvβ8 inhibitor in mouse tumor modelsRead more
day: Conference Day Two